BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2002

View Archived Issues

Nymox collaborates with Brown on cancer therapeutics and diagnostics

Read More

PPL presents roundup of key developments last year

Read More

Axokine phase III program expanded with two new studies

Read More

New orally active taxane, DJ-927, with a promising preclinical profile

Read More

NVP-LAF-389 induces amino-terminus changes in cytosolic protein indicative of enzyme inhibition

Read More

Proof of principle demonstrated for Corixa's duocarmycin/tumor-activated prodrug approach

Read More

New antimitotic indole-oxazoline derivative exhibits antivascular and proapoptotic effects

Read More

Small-molecule antimitotic agents a focus of cancer research at Abbott

Read More

CP-547632, a new oral VEGFR-2 tyrosine kinase inhibitor, advances to studies in humans

Read More

SAR on a series of group I metabotropic glutamate receptor antagonists reported at ACS meeting

Read More

Enrollment complete in second phase II trial of pexelizumab in acute myocardial infarction

Read More

Rhein Biotech licenses RC-529 for use in hepatitis B vaccines

Read More

Clinical update for GCS-100 (GBC-590) provided by GlycoGenesys

Read More

Roche to codevelop ISAtx-247 with Isotechnika

Read More

Ro-098246: a new triazole antifungal agent with improved potency and spectrum

Read More

Xanelim enters phase II trial in moderate to severe rheumatoid arthritis

Read More

E.U. submission for Arimidex in early-stage breast cancer in postmenopausal women

Read More

ACS news: design of new Zn2+-dependent inhibitor of HCV NS3 serine protease

Read More

Estradot launched in Germany for menopausal symptoms

Read More

Oratonin enters clinical testing for osteoporosis

Read More

Benzimidazoles and analogues claimed for treatment of inflammatory diseases

Read More

Eisai claims 2-aminopyridines with adenosine receptor-antagonist activity

Read More

Gepirone metabolite useful as antidepressant according to recent patent

Read More

New series of protein kinase inhibitors prepared at GSK

Read More

Scientists at AstraZeneca present new VEGF inhibitors and potential uses

Read More

Hypolipidemic agents acting via inhibition of apo B secretion described by Tanabe

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 11, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing